Clinical Trials Logo
  1. Home
  2. Patients
  3. NCT03790787

Drug Interaction Study Between Dorzagliatin and Empagliflozin

Patients Clinical Trial

Official title:
A Phase 1, Open-Label, Sequential, Multiple-Dose, Drug-Drug Interaction Study of Dorzagliatin and Empagliflozin in Subjects With Type 2 Diabetes Mellitus

Clinical Trial Summary

This is a Phase 1, open-label, sequential, multiple-dose, drug interaction study of glucokinase activator dorzagliatin and empagliflozin in subjects with T2DM. Pharmacokinetics and pharmacodynamics when dorzagliatin and empagliflozin given alone and in combination will be studied.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03790787
Study type Interventional
Source Hua Medicine Limited
Contact
Status Completed
Phase Phase 1
Start date April 18, 2019
Completion date March 15, 2020
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03943121 - The Effects of Steroid-eluting Stent Implant for the Treatment of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps N/A
Not yet recruiting NCT06040151 - Evaluating Mobile-based Medication Reconciliation by Patients at Home
Completed NCT04151004 - Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation N/A
Not yet recruiting NCT02968082 - The Effects of Preoperative Scopolamine Patch Application on the Postoperative Nausea and Vomiting in MVD Surgery Phase 4
Completed NCT01240967 - To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function Phase 1
Recruiting NCT06373614 - The Effect of Foot Massage and Bed Bath on Individuals With Cancer N/A
Recruiting NCT06396442 - Patient Worries Previous to Dental Treatment
Recruiting NCT05088161 - Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
Completed NCT03153579 - LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders Phase 2
Completed NCT03790839 - Drug Interaction Study Between Dorzagliatin and Sitagliptin Phase 1
Completed NCT02882672 - Changes in Adiponectin and Cardiovascular Disease Risk Factors in Overweight Patients Phase 1
Withdrawn NCT03837418 - DESIGNING A PROGRAMMING LANGUAGE FOR PATIENT-ORIENTED PRESCRIPTIONS (POP-PL)
Completed NCT03282630 - The Effects of Sphenopalatine Ganglion Acupuncture in Patients With Seasonal Allergic Rhinitis N/A
Recruiting NCT00001711 - Magnetic Resonance Imaging (MRI) Ofl Volunteers
Completed NCT02820168 - Designing a Programming Language for Patient-Oriented Prescriptions
Completed NCT01706744 - Effect of Discharge Via an Intermediate Care Unit N/A
Completed NCT04584554 - Enhancing the Transition From Hospital to Home for Patients With Traumatic Brain Injury and Families N/A
Completed NCT05660707 - Patients Who Underwent Surgical Procedures State of Readiness for Discharge
Completed NCT04632277 - Is Mg do Improve the Glycemic Control in Patients Drink a Desalinate Water N/A
Completed NCT05576701 - Laughter Therapy Application in Hemodialysis Patients N/A